Literature DB >> 15155404

Lower respiratory tract illness and RSV prophylaxis in very premature infants.

T Lacaze-Masmonteil1, P Truffert, D Pinquier, P Daoud, G Goldfarb, E Vicaut, B Fauroux.   

Abstract

AIMS: To determine the frequency of and the risk factors for readmissions for any lower respiratory tract illness (LRTI) and for respiratory syncytial virus (RSV) documented LRTI in children born very prematurely who had or had not received RSV prophylaxis.
METHODS: Multicentre prospective longitudinal cohort study of 2813 infants, born between April 2000 and December 2000 at less than 33 weeks of gestational age, and followed until the end of the epidemic season.
RESULTS: Among the 2256 children who had no bronchopulmonary dysplasia at 36 weeks of postmenstrual age and were not submitted to RSV prophylaxis, 27.4% were readmitted at least once for any reason during the epidemic season; 15.1% and 7.2% were readmitted at least once for any LRTI and RSV related LRTI, respectively. Children born at less than 31 weeks' gestation, having an intrauterine growth restriction, or living in a single mother family were at a significantly higher risk of readmission for LRTI in general as well as for RSV related LRTI. Of the 376 children submitted to prophylaxis, 28.2% were readmitted at least once for any LRTI and 6.1% for RSV related LRTI.
CONCLUSION: One out of four children who had received no prophylaxis, was born very prematurely, and was without bronchopulmonary dysplasia at 36 weeks of postmenstrual age, was readmitted at least once for any reason. Roughly 50% and 20% of these readmissions were related to a LRTI and an RSV infection, respectively. Further epidemiological studies are warranted to assess the aetiology and impact of other respiratory pathogens on post-discharge readmission and respiratory morbidity in this population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15155404      PMCID: PMC1719950          DOI: 10.1136/adc.2003.028282

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  18 in total

1.  The critical role of population-based epidemiology in cost-effectiveness research.

Authors:  S Joffe; T A Lieu; G J Escobar
Journal:  Pediatrics       Date:  2000-04       Impact factor: 7.124

2.  Influenza and hospitalizations in children.

Authors:  W P Glezen
Journal:  N Engl J Med       Date:  2000-06-08       Impact factor: 91.245

Review 3.  Respiratory syncytial virus and parainfluenza virus.

Authors:  C B Hall
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

4.  Rehospitalization for respiratory syncytial virus among premature infants.

Authors:  S Joffe; G J Escobar; S B Black; M A Armstrong; T A Lieu
Journal:  Pediatrics       Date:  1999-10       Impact factor: 7.124

5.  Bronchiolitis-associated hospitalizations among US children, 1980-1996.

Authors:  D K Shay; R C Holman; R D Newman; L L Liu; J W Stout; L J Anderson
Journal:  JAMA       Date:  1999-10-20       Impact factor: 56.272

6.  Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons.

Authors:  X Carbonell-Estrany; J Quero
Journal:  Pediatr Infect Dis J       Date:  2001-09       Impact factor: 2.129

7.  Association of rhinovirus infection with increased disease severity in acute bronchiolitis.

Authors:  Nikolaos G Papadopoulos; Maria Moustaki; Mariza Tsolia; Apostolos Bossios; Eleni Astra; Anargiroula Prezerakou; Dimitrios Gourgiotis; Dimitrios Kafetzis
Journal:  Am J Respir Crit Care Med       Date:  2002-05-01       Impact factor: 21.405

8.  Rates of hospitalization for respiratory syncytial virus infection among children in medicaid.

Authors:  T G Boyce; B G Mellen; E F Mitchel; P F Wright; M R Griffin
Journal:  J Pediatr       Date:  2000-12       Impact factor: 4.406

9.  Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: a prospective study. IRIS Study Group.

Authors:  X Carbonell-Estrany; J Quero; G Bustos; A Cotero; E Doménech; J Figueras-Aloy; J M Fraga; L G García; A García-Alix; M G Del Río; X Krauel; J B Sastre; E Narbona; V Roqués; S S Hernández; M Zapatero
Journal:  Pediatr Infect Dis J       Date:  2000-07       Impact factor: 2.129

10.  Survival of very preterm infants: Epipage, a population based cohort study.

Authors:  B Larroque; G Bréart; M Kaminski; M Dehan; M André; A Burguet; H Grandjean; B Ledésert; C Lévêque; F Maillard; J Matis; J C Rozé; P Truffert
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-03       Impact factor: 5.747

View more
  12 in total

1.  Risk factors for hospitalization due to respiratory syncytial virus infection among infants in the Basque Country, Spain.

Authors:  G Cilla; A Sarasua; M Montes; N Arostegui; D Vicente; E Pérez-Yarza; E Pérez-Trallero
Journal:  Epidemiol Infect       Date:  2006-06       Impact factor: 2.451

2.  Diminished lung function, RSV infection, and respiratory morbidity in prematurely born infants.

Authors:  S Broughton; R Bhat; A Roberts; M Zuckerman; G Rafferty; A Greenough
Journal:  Arch Dis Child       Date:  2005-09-27       Impact factor: 3.791

3.  Preventing hospitalizations for respiratory syncytial virus infection.

Authors:  Joan L Robinson; Nicole Le Saux
Journal:  Paediatr Child Health       Date:  2015 Aug-Sep       Impact factor: 2.253

4.  Randomised trial of high frequency oscillatory ventilation or conventional ventilation in babies of gestational age 28 weeks or less: respiratory and neurological outcomes at 2 years.

Authors:  N Marlow; A Greenough; J L Peacock; L Marston; E S Limb; A H Johnson; S A Calvert
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-05-11       Impact factor: 5.747

5.  Prospective study of healthcare utilisation and respiratory morbidity due to RSV infection in prematurely born infants.

Authors:  S Broughton; A Roberts; G Fox; E Pollina; M Zuckerman; S Chaudhry; A Greenough
Journal:  Thorax       Date:  2005-10-14       Impact factor: 9.139

6.  Epidemiology and virology of acute respiratory infections during the first year of life: a birth cohort study in Vietnam.

Authors:  Katherine L Anders; Hoa L Nguyen; Nguyet Minh Nguyen; Nguyen Thi Van Thuy; Nguyen Thi Hong Van; Nguyen Trong Hieu; Nguyen Thi Hong Tham; Phan Thi Thanh Ha; Le Bich Lien; Nguyen Van Vinh Chau; Vu Thi Ty Hang; H Rogier van Doorn; Cameron P Simmons
Journal:  Pediatr Infect Dis J       Date:  2015-04       Impact factor: 2.129

Review 7.  Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World Perspective.

Authors:  Nusrat Homaira; William Rawlinson; Thomas L Snelling; Adam Jaffe
Journal:  Int J Pediatr       Date:  2014-12-04

Review 8.  Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children.

Authors:  Eric A F Simões; Louis Bont; Paolo Manzoni; Brigitte Fauroux; Bosco Paes; Josep Figueras-Aloy; Paul A Checchia; Xavier Carbonell-Estrany
Journal:  Infect Dis Ther       Date:  2018-02-22

9.  Palivizumab: a review of its use in the protection of high risk infants against respiratory syncytial virus (RSV).

Authors:  Joseph M Geskey; Neal J Thomas; Gretchen L Brummel
Journal:  Biologics       Date:  2007-03

10.  Respiratory syncytial virus disease in preterm infants in the U.S. born at 32-35 weeks gestation not receiving immunoprophylaxis.

Authors:  Christopher S Ambrose; Evan J Anderson; Eric A F Simões; Xionghua Wu; Hanaa Elhefni; C Lucy Park; Frangiscos Sifakis; Jessie R Groothuis
Journal:  Pediatr Infect Dis J       Date:  2014-06       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.